ArticleBlood cancer journal2016

Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini.

D J Kowalewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.